- Supernus Pharmaceuticals (NASDAQ:SUPN): Q3 GAAP EPS of $0.74 beats by $0.47.
- Revenue of $155.14M (+51.9% Y/Y) beats by $24.38M.
- Raises 2020 Guidance: Net product sales increased to $500-$525M from $460-500M, and operating earnings of $145-$160M from $90-110M.
- https://seekingalpha.com/news/3630784-supernus-pharmaceuticals-eps-beats-0_47-beats-on-revenue
Tuesday, November 3, 2020
Supernus Pharmaceuticals EPS beats by $0.47, beats on revenue
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.